Skip to content

A Home-based Exercise and Physical Activity Intervention After Liver Transplantation: Impact of Exercise Intensity

A Home-based Exercise and Physical Activity Intervention After Liver Transplantation: Impact of Exercise Intensity - a Monocenter Randomized Controlled Trial [PHOENIX-Liver]

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06302205
Acronym
PHOENIX-L
Enrollment
147
Registered
2024-03-08
Start date
2023-03-01
Completion date
2026-12-31
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation, Physical Fitness

Keywords

Exercise Intensity

Brief summary

Research demonstrated that transplant recipients benefit from physical activity, but there is a gap in knowledge regarding the required intensity. In the PHOENIX-Liver study, researchers aim to investigate the adequate intensity of rehabilitation programs after liver transplantation. Patients will be randomized into one of the three PHOENIX-Liver training groups (low, moderate, moderate to high). The six months rehabilitation program is conducted from the patient's home but supervised by a PHOENIX-investigator. At baseline, after three months of rehabilitation and after six months of rehabilitation, a test moment takes place at which physical fitness, cardiovascular health, liver function, and body composition will be assessed. Questionnaires are taken monthly to survey well-being, safety, quality of life, physical activity, and cost-effectiveness. To gather information on the potential for implementation in a real-world setting, a 15-month-long physical activity phase will start after the intervention phase. This entails a maintenance physical activity program tailored to the patients' preferences. A follow-up at UZ Leuven is planned at three and at 15 months where the same clinical evaluations will be conducted as during the test moments of the intervention phase.

Detailed description

Liver transplantation constitutes the only curative treatment for patients with end-stage liver disease. Advances in the field have led to favourable short- and medium term (1-3 year) post-transplant survival rates, but improvement in long-term survival rates remains disappointing. Due to the immunosuppressive therapy, a sedentary lifestyle and a poor recovery of post-transplant physical fitness, the proportion of liver transplant recipients that develop a new-onset or a deteriorating unfavourable cardiovascular risk profile is alarmingly high, and cardiovascular disease is the leading cause of death in this population. By consequence, in order to improve long-term outcome after liver transplantation, prevention of cardiovascular disease should be prioritized. The investigators are convinced that the challenge of cardiovascular disease and lack of physical fitness in liver transplant recipients should and can be addressed by subjecting these patients to a structured physical rehabilitation program. The aim of this project is implement a structured, individually-tailored, home-based but supervised physical rehabilitation and maintenance program for de novo liver transplantation recipients, and to demonstrate the feasibility and safety of such approach as well as its efficacy to improve physical fitness. The program will consist of a 2-phase intervention of i) home-based exercise training (aerobic exercise training as well as strength, flexibility and stability exercises under in-person and subsequently remote guidance) and ii) an 15-month maintenance phase of physical activity. This program will be studied in an open-label randomized trial where the regimen will be compared with a regimen of standard of posttransplant care. In addition to the interventional arm, two different regimens of exercise training intensity will also be studied.

Interventions

OTHERPhysical activity

The home-based training intervention consists of two phases of each three months in duration. It consists of three weekly aerobic training sessions on the one hand, and two weekly training sessions focused on strength, balance, and flexibility on the other hand.

OTHERSham intervention

2 times a week, flexibility and balance training

Sponsors

KU Leuven
CollaboratorOTHER
Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The nature of the intervention does not allow blinding of study participants. However, outcome assessors and data investigators will be blinded to the participants' group allocation.

Intervention model description

Two interventional groups and one control group

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* de novo adult liver transplant recipients with a transplant vintage of two to three months * access to a home freezer (± -18°C)

Exclusion criteria

* Aberrant CPET (abnormal low cardiorespiratory fitness is not considered an

Design outcomes

Primary

MeasureTime frameDescription
Cardiorespiratory fitnessAt 0, 3 and 6 months of the interventional rehabilitation programme and at 15 months after the end of the interventionChanges in peak oxygen uptake (mL O2·min-1·kg-1) assessed by cardiopulmonary exercise test

Secondary

MeasureTime frameDescription
Hand grip strengthAt 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the interventionassessement by means of Jamar Hydraulic Hand Dynamometry (kg)
Knee-extensor strengthAt 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the interventionassessement by means of Biodex dynamometer (Nm)
Endothelial functionAt 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the interventionassessed via flow mediated dilation
Arterial stiffnessAt 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the interventionassessed via pulse wave velocity
Functional exercise capacitiyAt 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the interventionsix-minute walking test (m)
Occurence of adverse eventsMonthlySafety is estimated by means of questionnaires
Motor fitnessAt 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the interventionShort Physical Performance Battery test
Blood pressureAt 0, 3 and 6 months of the interventional rehabilitation programme and 15 months after the end of the interventionVariation in blood pressure measured by means of automatic device (Omron M6) in fasted condition and without medication taken in
Blood profileAt 0, 3 and 6 months of the interventional rehabilitation programme, and at 3 and 15 months after the end of the interventionBlood is drawn when patient is in fasted condition and did not take their medication
Graft functionAt 0 and after 21 monthsTransient elastography Fibroscan assessing liver stiffness

Countries

Belgium

Contacts

Primary ContactDiethard Monbaliu, MD PhD
diethard.monbaliu@uzleuven.be+3216342361
Backup ContactStefan De Smet, PhD
stefan.desmet@kuleuven.be

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026